Secondary Logo

Most Popular Articles

A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

Hobart, Mary; Zhang, Peter; Skuban, Aleksandar; More

Journal of Clinical Psychopharmacology. 39(3):203-209, May/June 2019.

Zonisamide, Topiramate, and Levetiracetam: Efficacy and Neuropsychological Effects in Alcohol Use Disorders

Knapp, Clifford M.; Ciraulo, Domenic A.; Sarid-Segal, Ofra; More

Journal of Clinical Psychopharmacology. 35(1):34-42, February 2015.

Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial

Mazereeuw, Graham; Herrmann, Nathan; Oh, Paul I.; More

Journal of Clinical Psychopharmacology. 36(5):436-444, October 2016.

Speed of Improvement in Symptoms of Depression With Desvenlafaxine 50 mg and 100 mg Compared With Placebo in Patients With Major Depressive Disorder

Katzman, Martin A.; Nierenberg, Andrew A.; Wajsbrot, Dalia B.; More

Journal of Clinical Psychopharmacology. 37(5):555-561, October 2017.

N-Acetylcysteine Add-On Treatment in Refractory Obsessive-Compulsive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Afshar, Hamid; Roohafza, Hamidreza; Mohammad-Beigi, Hamid; More

Journal of Clinical Psychopharmacology. 32(6):797-803, December 2012.

Driving Performance Under Alcohol in Simulated Representative Driving Tasks: An Alcohol Calibration Study for Impairments Related to Medicinal Drugs

Kenntner-Mabiala, Ramona; Kaussner, Yvonne; Jagiellowicz-Kaufmann, Monika; More

Journal of Clinical Psychopharmacology. 35(2):134-142, April 2015.

Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial

Evins, A. Eden; Benowitz, Neal L.; West, Robert; More

Journal of Clinical Psychopharmacology. 39(2):108-116, March/April 2019.

Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study

Göhler, Karin; Sokolowska, Marta; Schoedel, Kerri A.; More

Journal of Clinical Psychopharmacology. 39(1):46-56, January/February 2019.

A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

Zabala, Arantzazu; Bustillo, Mariana; Querejeta, Imanol; More

Journal of Clinical Psychopharmacology. 37(5):569-577, October 2017.

Twenty-Four–Hour Measures of Heart Rate–Corrected QT Interval, Peak-to-End of the T-Wave, and Peak-to-End of the T-Wave/Corrected QT Interval Ratio During Antipsychotic Treatment

Tümüklü, Mevhibe N.; Tümüklü, Mustafa M.; Nesterenko, Vladislav; More

Journal of Clinical Psychopharmacology. 39(2):100-107, March/April 2019.

A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults

Richards, Cynthia; Iosifescu, Dan V.; Mago, Rajnish; More

Journal of Clinical Psychopharmacology. 38(4):336-343, August 2018.

Medication Adherence in Outpatients With Severe Mental Disorders: Relation Between Self-Reports and Serum Level

Jónsdóttir, Halldóra; Opjordsmoen, Stein; Birkenaes, Astrid B.; More

Journal of Clinical Psychopharmacology. 30(2):169-175, April 2010.

A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder

Gasior, Maria; Hudson, James; Quintero, Javier; More

Journal of Clinical Psychopharmacology. 37(3):315-322, June 2017.

Aripiprazole Once-Monthly in the Treatment of Acute Psychotic Episodes in Schizophrenia: Post Hoc Analysis of Positive and Negative Syndrome Scale Marder Factor Scores

Ismail, Zahinoor; Peters-Strickland, Timothy; Miguelez, Maia; More

Journal of Clinical Psychopharmacology. 37(3):347-350, June 2017.

Long-Term Effect of Haloperidol, Olanzapine, and Risperidone on Plasma Prolactin Levels in Patients With First-Episode Psychosis

Pérez-Iglesias, Rocio; Mata, Ignacio; Martínez-García, Obdulia; More

Journal of Clinical Psychopharmacology. 32(6):804-808, December 2012.

Characterization of the Safety and Pharmacokinetic Profile of D-Methadone, a Novel N-Methyl-D-Aspartate Receptor Antagonist in Healthy, Opioid-Naive Subjects: Results of Two Phase 1 Studies

Bernstein, Galina; Davis, Kelly; Mills, Catherine; More

Journal of Clinical Psychopharmacology. 39(3):226-237, May/June 2019.

A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares

McCall, William Vaughn; Pillai, Anilkumar; Case, Doug; More

Journal of Clinical Psychopharmacology. 38(6):618-621, December 2018.

An 8-Week, Randomized, Phase 2, Double-Blind, Sequential Parallel-Group Comparison Study of Two Dose Levels of the GABAA Positive Allosteric Modulator PF-06372865 Compared With Placebo as an Adjunctive Treatment in Outpatients With Inadequate Response to Standard of Care for Generalized Anxiety Disorder

Simen, Arthur; Whitlock, Mark; Qiu, Ruolun; More

Journal of Clinical Psychopharmacology. 39(1):20-27, January/February 2019.

Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study

Sanches, Rafael Faria; de Lima Osório, Flávia; dos Santos, Rafael G.; More

Journal of Clinical Psychopharmacology. 36(1):77-81, February 2016.

The Effects of BDNF Val66Met Gene Polymorphism on Serum BDNF and Cognitive Function in Methamphetamine-Dependent Patients and Normal Controls: A Case-Control Study

Su, Hang; Tao, Jingyan; Zhang, Jie; More

Journal of Clinical Psychopharmacology. 35(5):517-524, October 2015.

Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review

Grall-Bronnec, Marie; Sauvaget, Anne; Perrouin, Fanny; More

Journal of Clinical Psychopharmacology. 36(1):63-70, February 2016.

Complexity of Illness and Adjunctive Benzodiazepine Use in Outpatients With Bipolar I or II Disorder: Results From the Bipolar CHOICE Study

Bobo, William V.; Reilly-Harrington, Noreen A.; Ketter, Terence A.; More

Journal of Clinical Psychopharmacology. 35(1):68-74, February 2015.

The Prescription of Benzodiazepines for Panic Disorder: Time for an Evidence-Based Educational Approach

Nardi, Antonio E.; Cosci, Fiammetta; Balon, Richard; More

Journal of Clinical Psychopharmacology. 38(4):283-285, August 2018.

Show: